These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 14523782)

  • 1. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada.
    Knowles SR; Phillips EJ; Dresser L; Matukas L
    Clin Infect Dis; 2003 Oct; 37(8):1139-42. PubMed ID: 14523782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome.
    Muller MP; Dresser L; Raboud J; McGeer A; Rea E; Richardson SE; Mazzulli T; Loeb M; Louie M;
    Pharmacotherapy; 2007 Apr; 27(4):494-503. PubMed ID: 17381375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The war against an unknown pathogen: rising to the SARS challenge.
    Can Commun Dis Rep; 2003 May; 29(9):77-82. PubMed ID: 12739275
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse effects of ribavirin and outcome in severe acute respiratory syndrome: experience in two medical centers.
    Chiou HE; Liu CL; Buttrey MJ; Kuo HP; Liu HW; Kuo HT; Lu YT
    Chest; 2005 Jul; 128(1):263-72. PubMed ID: 16002945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral treatment of SARS: can we draw any conclusions?
    Zhaori G
    CMAJ; 2003 Nov; 169(11):1165-6. PubMed ID: 14638651
    [No Abstract]   [Full Text] [Related]  

  • 6. Current concepts in SARS treatment.
    Fujii T; Nakamura T; Iwamoto A
    J Infect Chemother; 2004 Feb; 10(1):1-7. PubMed ID: 14991510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials and novel pathogens: lessons learned from SARS.
    Muller MP; McGeer A; Straus SE; Hawryluck L; Gold WL
    Emerg Infect Dis; 2004 Mar; 10(3):389-94. PubMed ID: 15109402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribavarin should be tested in clinical trials in combination with other antiviral agents for severe acute respiratory syndrome.
    Chu CM; Chan KS
    Chest; 2005 Dec; 128(6):4050. PubMed ID: 16354884
    [No Abstract]   [Full Text] [Related]  

  • 9. Ribavirin trials and hantavirus--what we should not conclude.
    Marcus KA; Johann-Liang R; Powers JH
    Clin Infect Dis; 2005 May; 40(10):1550-1. PubMed ID: 15844085
    [No Abstract]   [Full Text] [Related]  

  • 10. Ribavirin in the treatment of severe acute respiratory syndrome (SARS).
    van Vonderen MG; Bos JC; Prins JM; Wertheim-van Dillen P; Speelman P
    Neth J Med; 2003 Jul; 61(7):238-41. PubMed ID: 14567520
    [No Abstract]   [Full Text] [Related]  

  • 11. Outcome of coronavirus-associated severe acute respiratory syndrome using a standard treatment protocol.
    Lau AC; So LK; Miu FP; Yung RW; Poon E; Cheung TM; Yam LY
    Respirology; 2004 Jun; 9(2):173-83. PubMed ID: 15182266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early decline of hemoglobin correlates with progression of ribavirin-induced hemolytic anemia during interferon plus ribavirin combination therapy in patients with chronic hepatitis C.
    Oze T; Hiramatsu N; Kurashige N; Tsuda N; Yakushijin T; Kanto T; Takehara T; Kasahara A; Kato M; Yoshihara H; Katayama K; Kubota S; Hijioka T; Ishibashi K; Oshita M; Hagiwara H; Haruna Y; Mita E; Tamura S; Hayashi N
    J Gastroenterol; 2006 Sep; 41(9):862-72. PubMed ID: 17048050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cluster of cases of severe acute respiratory syndrome in Hong Kong.
    Tsang KW; Ho PL; Ooi GC; Yee WK; Wang T; Chan-Yeung M; Lam WK; Seto WH; Yam LY; Cheung TM; Wong PC; Lam B; Ip MS; Chan J; Yuen KY; Lai KN
    N Engl J Med; 2003 May; 348(20):1977-85. PubMed ID: 12671062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS: pharmacotherapy.
    Tsang K; Zhong NS
    Respirology; 2003 Nov; 8 Suppl():S25-30. PubMed ID: 15018130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [SARS: a new emergency in the world health].
    Calza L; Manfredi R; Verucchi G; Chiodo F
    Recenti Prog Med; 2003; 94(7-8):284-94. PubMed ID: 12868233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribavirin for SARS in children.
    Cheng WT; Li CK; Leung TF; Li AM; Hon KL; Ng PC; Fok TF
    Clin Pediatr (Phila); 2004 Mar; 43(2):193-6. PubMed ID: 15024445
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe acute respiratory syndrome: clinical outcome and prognostic correlates.
    Tsui PT; Kwok ML; Yuen H; Lai ST
    Emerg Infect Dis; 2003 Sep; 9(9):1064-9. PubMed ID: 14519241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum hepatic enzyme manifestations in patients with severe acute respiratory syndrome: retrospective analysis.
    Cui HJ; Tong XL; Li P; Hao YX; Chen XG; Li AG; Zhang ZY; Duan J; Zhen M; Zhang B; Hua CJ; Gong YW
    World J Gastroenterol; 2004 Jun; 10(11):1652-5. PubMed ID: 15162543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis in a SARS outbreak.
    Wong CY; Wong KY; Law TS; Shum TT; Li YK; Pang WK
    J Chin Med Assoc; 2004 Nov; 67(11):579-82. PubMed ID: 15720073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe acute respiratory syndrome (SARS) in Hong Kong.
    Tsang KW; Mok TY; Wong PC; Ooi GC
    Respirology; 2003 Sep; 8(3):259-65. PubMed ID: 14528875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.